Association of urinary albumin excretion with insulin resistance in Japanese subjects: Impact of gender difference on insulin resistance

Internal Medicine

Volumn 48, Issue 18, 2009, Pages 1621-1627

  Utsunomiya, Kazunori ^a   Takamatsu, Keita ^b   Fukuta, Isao ^c   Sakamoto, Hisashi ^c   Ishizawa, Sho ^a   Kanazawa, Yasushi ^a   Gojo, Atsushi ^a   Taniguchi, Kanta ^a   Yokota, Tamotsu ^a   Kurata, Hideaki ^a   Nomura, Kouji ^b   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nomura Hospital Center of Preventive Medicine   (Japan)

^c ARKRAY Healthcare Pvt Ltd   (Japan)

Author keywords

CKD; Diabetes; Diabetic nephropathy; Insulin resistance; Metabolic syndrome; Microalbuminuria

Indexed keywords

ALBUMIN; TRIACYLGLYCEROL;

ADULT; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; WAIST CIRCUMFERENCE;

ADULT; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CREATININE; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; JAPAN; LIPIDS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY, ABDOMINAL; RISK FACTORS; SEX CHARACTERISTICS;

EID: 70349507141     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2287     Document Type: Article

References (28)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C.Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004(Erratum in: N Engl J Med 18:4, 2008).
2. Ninomiya T, Kiyohara Y, Kubo H, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 68: 228-236, 2005.
3. Hallan S, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 333: 1047-1050, 2006.
4. Gerstein HC, Mann JFE, Yi Q, et al. For the HOPE Study Investigation. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426, 2001.
5. Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl 92: S59-S62, 2004.
6. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949, 2005.
7. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062, 2005.
8. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112: 2735-2752, 2005(Erratum in: Circulation 112 : s297, e298, 2005).
9. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. PREVEND Study Group. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28: 2525-2530, 2005.
10. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004.
11. Klausen KP, Parving HH, Scharling H, Jensen JS. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262: 470-478, 2007.
12. Luk AOY, So W, Ma RC, et al; Hong Kong Diabetes Registry. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31: 2357-2361, 2008.
13. Bianchi S, Bigazzi R, Quinones Galvan A, et al. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 26: 789-795, 1995.
14. Parvanova AI, Trevisan R, Iliev IP, et al. Insulin resistance and microalbuminuira. A cross-sectional, case control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 55: 1456-1462, 2006.
15. De Cosmo SD, Minenna A, Ludovico O, et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sexspecific association. Diabetes Care 28: 910-915, 2005.
16. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
18. Matsuo S, Imai E, Horio M, et al. Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
19. Alberti KG, Zimmet P, Shaw J. International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med 24: 451-463, 2007.
20. Haffner SM, Gonzales C, Valdez RA, et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 36: 1002-1006, 1993.
21. Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 41: 694-700, 1998.
22. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005.
23. Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, Jong PE. PREVEND Study Group. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 14: 1330-1335, 2003.
24. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 13: 1626-1634, 2002.
25. Chin M, Isono M, Isshiki K, et al. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am J Pathol 166: 1629-1636, 2005.
26. Neugarten JN, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am J Nephrol 11: 319-329, 2000.
27. Fukui M, Ose H, Nakayama I, et al. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes. Diabetes Care 30: 1886-1888, 2007.
28. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata study. Kidney Int 70: 751-756, 2006.